Industry reports 88 deals worth $11.1B in July 2024: GlobalData
The lifesciences sector also reported 73 VC deals worth $2.5 billion
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Eli Lilly and Company
US FDA to Review Eli Lilly’s Donanemab for Early Alzheimer’s Treatment
The meeting is set to be held on June 10, 2024
US FDA approves Jardiance to treat adults living with heart failure with reduced ejection fraction
Heart failure accounts for more than one million hospitalisations a year in the US
Bajaj Healthcare applies to Indian patent office for compulsory licence for Baricitinib
Considering Bajaj Healthcare's manufacturing capabilities and strong in-house R&D team, we can produce Baricitinib at very…
Mankind Pharma partners with BDR Pharma to distribute Baricitinib in India
BDR Pharma will be manufacturing and marketing the product under a royalty-free, limited and non-exclusive voluntary licence from…
European Commission approves Jardiance to treat heart failure
This new indication is based on the EMPEROR-Reduced trial, which showed a significant 25 per cent reduction in the combined…
AbCellera gets EUA from US FDA for its antibody Bamlanivimab, along with Etesevimab for COVID-19
Lilly plans to manufacture more than 250,000 doses of the bamlanivimab and etesevimab therapy throughout Q1 2021, and up to a…
US DOJ permits six drug makers to share info about COVID-19 MAb treatments to expedite production
The approval granted through a business review letter from the Justice Department's antitrust division, however, has not allowed…
Healthcare industry reports 70 deals worth $3.2-bn in Jan ’20
The healthcare industry reported 98 VC deals worth $1.9-billion in January 2020, compared to the last 12-month average of 103…
Eli Lilly and Company, Merck enter collaboration agreement
To research immuno-oncology combination regimens in multiple types of cancer